JD Health International, Inc. (HK:6618) has released an update.
JD Health International, Inc. reported a significant rise in revenue and profits for the third quarter of 2024, with revenue increasing by 14.8% and profit surging by 212.2% compared to the same period in 2023. The company expanded its pharmaceutical offerings and online medical services, enhancing its service model by integrating online consultations and at-home testing services in major cities like Beijing and Shanghai. JD Health also introduced online payment services through medical insurance accounts, further solidifying its position in the healthcare market.
For further insights into HK:6618 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Pounds the Table on Tesla Stock
- ‘Breath of Fresh Air,’ Says Daniel Ives About Rivian Stock
- ‘It’s Not Too Late to Load Up,’ Says Analyst About Nvidia Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
